Indo Us Bio-Tech

Indo Us Bio-Tech ROE

The Return on Equity (ROE) of Indo Us Bio-Tech (INDOUS.NS) as of Oct 16, 2026 is 14.18 %. In the previous year, Return on Equity (ROE) was 20.72 % — a change of -31.55% (lower).

ROE

14.18 %

YoY

-31.55%

Last updated:

In 2026, Indo Us Bio-Tech's return on equity (ROE) was 14.18 %, a -31.55% increase from the 20.72 % ROE in the previous year.

The Indo Us Bio-Tech ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
15.02 INR
Jan 1, 2020
15.42 INR
Jan 1, 2021
23.67 INR
Jan 1, 2022
13.15 INR
Jan 1, 2023
13.29 INR
Jan 1, 2024
13.13 INR
Jan 1, 2025
20.72 INR
Jan 1, 2026
14.18 INR
The Indo Us Bio-Tech ROE history
YEARROEYoY
14.18 %-31.55%
20.72 %+57.76%
13.13 %-1.15%
13.29 %+1.04%
13.15 %-44.44%
23.67 %+53.52%
15.42 %+2.67%
15.02 %-48.80%
29.33 %+159.42%
11.30 %+38.98%
8.13 %-52.41%
17.09 %+38.05%
12.38 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Indo Us Bio-Tech Stock analysis

What does Indo Us Bio-Tech do? Indo Us Bio-Tech is one of the most popular companies on Eulerpool.

ROE Details

Decoding Indo Us Bio-Tech's Return on Equity (ROE)

Indo Us Bio-Tech's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Indo Us Bio-Tech's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Indo Us Bio-Tech's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Indo Us Bio-Tech’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Indo Us Bio-Tech stock

Return on Equity (ROE) of Indo Us Bio-Tech is 14.18 % in 2026.

Return on Equity (ROE) of Indo Us Bio-Tech changed from 20.72 % to 14.18 %, representing a -31.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Indo Us Bio-Tech since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Indo Us Bio-Tech with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Indo Us Bio-Tech

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Indo Us Bio-Tech